Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Applauds Senate Judiciary Committee for Advancing the CREATES Act

June 15, 2018 by admin 2018 Press Releases 0 comments

Washington, DC (June 14, 2018) – Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released the following statement applauding the Senate Judiciary Committee members for voting to advance the CREATES Act:

“The Healthcare Supply Chain Association (HSCA) applauds and thanks Chairman Grassley, Senator Leahy and all Senate Judiciary Committee members who voted to advance the CREATES Act for leading the effort to reduce prescription drug prices for patients. Americans rely on generic drugs to reduce costs and increase access to essential medications, and price spikes for commonly used drugs jeopardize patient access to care. HSCA will continue to advocate for policy solutions like the CREATES Act that lower drug prices, encourage competition and innovation in the marketplace, and end anti-competitive abuses utilized by some brand-name manufactures. We urge the Senate to pass the CREATES Act to help protect patient access to affordable prescription drugs for healthcare providers and the patients they serve.”

Prev
Next

Related Posts

HSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids
March 9, 2018

Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph.,...

Learn more
HSCA Announces Healthcare Cybersecurity Key Considerations
April 17, 2018

The Healthcare Supply Chain Association (HSCA) today announced the release of key...

Learn more
HSCA Comments on DEA Proposed Rule on Opioid Production Limits
May 4, 2018

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
HSCA Comments on FDA Bulk Substance Guidance
May 25, 2018

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HEALTHCARE SUPPLY CHAIN ASSOCIATION ANNOUNCES HSCA CONNECT AFFILIATE PROGRAM TO IMPROVE SUPPLY CHAIN PROCESSES ACROSS THE HEALTHCARE CONTINUUM
    March 20, 2023
  • HSCA Response to Congressional RFI on the Pandemic and All-Hazards Preparedness Act (PAHPA)
    March 16, 2023